For the year ending 2025-12-31, RLYB made $858K in revenue. -$9,028K in net income. Net profit margin of -1052.21%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenue | 858 | |||
| Research and development | 19,597 | |||
| General and administrative | 14,325 | |||
| Total operating expenses | 33,922 | |||
| Loss from operations | -33,064 | |||
| Interest income | 2,189 | |||
| Gain on sale of joint venture and other income | 22,771 | |||
| Total other income, net | 24,960 | |||
| Loss before equity in losses of joint venture | -8,104 | |||
| Loss on investment in joint venture | -874 | |||
| Net loss | -8,978 | |||
| Net unrealized (loss) gain on marketable securities | -50 | |||
| Other comprehensive (loss) gain | -50 | |||
| Comprehensive loss | -9,028 | |||
| Basic EPS | -1.59 | |||
| Diluted EPS | -1.59 | |||
| Basic Average Shares | 5,629,370 | |||
| Diluted Average Shares | 5,629,370 | |||
Rallybio Corp (RLYB)
Rallybio Corp (RLYB)